10.1002/anie.201811093
Angewandte Chemie International Edition
COMMUNICATION
aldehyde 30 to install the C17/C18 alkene while the
benzothiazolyl (BT) sulfone remained intact. The corresponding
sulfone 31 was then achieved in 83% isolated yield with an
excellent stereoselectivity (Z/E > 20/1).
pair of enantiomers, which were readily derived from the
decagram scale kinetic resolution of racemic α-allenic alcohol (15
longest linear steps from readily available rac-10, 12% overall
yield). The unprecedented iterative hydroboration/oxidation
converted the allene into the stereotriad of the B-ring. A cascade
process to construct the A-ring was superb and offers a platform
for derivatization. Moreover, for the first time, metastable borinate
and borane-ate complex were designed as traceless protection to
facilitate the crucial stereoselective hydroboration of allene and
alkene, debenzylation, and Julia olefination, which save additional
protection and deprotection operations. It is also noteworthy that
the reactivity-oriented design of bissulfone provided a C3-
homologation linker to react with two distinct aldehydes through a
sequential manner. The overall synthesis sequence also
circumvents additional transition metal removal steps.[35] By
implementing our previous tactics for the construction of
tetrahydropyran stereoisomers,[12] more macrolide analogs can
be assembled for future medicinal development.
A direct application of the free dienyl acid 21 (Scheme 5) to
Julia reaction was unsuccessful, suggesting protection of the acid
group to be necessary. Primary mechanistic studies revealed that
the complexation of the acid 21 with 9-BBN was complete after
30 min at 50 oC and two new signals (21a and 21b) were shown
in the 11B NMR spectra (32.8 and 19.7 ppm).[16,32] The ate-
complex was stable enough at room temperature and no
appreciable reduction of aldehyde was observed (Figure S7). To
this borane ate-complex solution, sulfone 31 and LiHMDS were
o
added at -75 C for the requisite Julia olefination. After acidic
work-up, the E-isomer of seco acid 32 was isolated in 65% yield.[33]
Finally, Yamaguchi macrolactonization[34] and subsequent global
desilylation were adopted to deliver the target molecule, (-)-
lasonolide A (4) (58% yield, 35.8 mg). The spectroscopic data of
the synthetic sample were identical to the original data [7] as well
as those reported in other synthetic studies.[9]
Acknowledgments
Financial support from the MOST Innovative Drug Discovery
(2018ZX09711001-005), the Shanghai Science and Technology
Foundation of China (21472223), and the Chinese Academy of
Sciences (QYZDY-SSWSLH026 and XDB20020100) is highly
appreciated. We thank Jie Sun (SIOC) for the X-ray analysis and
Wenhua Li (SIOC) for assistance with the biotransformation.
Keywords: borane • hydroboration • macrolactonization •
olefination • oxa-Michael
References
[1] (a) H. C. Brown, B. C. Subba Rao, J. Am. Chem. Soc. 1956, 78, 5694; (b)
H. C. Brown, B. C. Subba Rao, J. Org. Chem. 1957, 22, 1336.
[2] (a) H. C. Brown, Tetrahedron 1961, 12, 117; (b) H. C. Brown, Boranes in
Organic Chemistry, Cornell University, Ithaca, NY, 1972; (c) H. C. Brown,
C. Snyder, B. C. Subba Rao, G. Zweifel, Tetrahedron 1986, 42, 5505.
[3] The mono-oxidation product (borinate) was characterized for selected
substances when stochiometric oxidant (e.g. trimethylamine N-oxide) was
utilized, see: J. A. Soderquist, M. R. Najafi, J. Org. Chem. 1986, 51, 1330.
[4] (a) T. W. Green, P. G. Wuts, Protective Groups in Organic Synthesis, 3rd
Ed.; Wiley, 1999; (b) P. J. Kocienski, Protecting Groups, 3rd Ed.; Thieme:
New York, 2005.
[5] T. Gaich, P. S. Baran, J. Org. Chem. 2010, 75, 4657.
[6] (a) K.-S. Yeung, I. Paterson, Chem. Rev. 2005, 105, 4237; (b) P. S. Baran,
T. J. Maimone, J. M. Richter, Nature 2007, 446, 404.
[7] (a) P. A. Horton, F. E. Koehn, R. E. Longley, O. J. McConnell, J. Am. Chem.
Soc. 1994, 116, 6015; (b) A. E. Wright, Y. Chen, P. L. Winder, T. P. Pitts, S.
A. Pomponi, R. E. Longley, J. Nat. Prod. 2004, 67, 1351.
[8] (a) M. C. Alley, D. A. Scudiero, A. Monks, M. L. Hursey, M. J. Czerwinski,
D. L. Fine, B. J. Abbott, J. G. Mayo, R. H. Shoemaker, M. R. Boyd, Cancer
Res. 1988, 48, 589; (b) R. A. Isbrucker, E. A. Guzmán, T. P. Pitts, A. E.
Wright, J. Pharmacol. Exp. Ther. 2009, 331, 733; (c) Y.-W. Zhang, A. K.
Ghosh, Y. Pommier, Cell Cycle 2012, 11, 4424; (d) R. Jossé, Y.-W. Zhang,
V. Giroux, A. K. Ghosh, J. Luo, Y. Pommier, Mar. Drugs 2015, 13, 3625; (e)
H.-S. Lee, N. C. O. Lee, N. Kouprina, J.-H. Kim, A. Kagansky, S. Bates, J.
B. Trepel, Y. Pommier, D. Sackett, V. Larionov, Cancer Res. 2016, 76, 902.
[9] (a) E. Lee, H. Y. Song, J. W. Kang, D.-S. Kim, C.-K. Jung, J. M. Joo, J. Am.
Chem. Soc. 2002, 124, 384; (b) S. H. Kang, S. Y. Kang, C. M. Kim, H.-w.
Choi, H. S. Jun, B. M. Lee, C. M. Park, J. W. Jeong, Angew. Chem., Int. Ed.
2003, 42, 4779; Angew. Chem. 2003, 115, 4927; (c) T. Yoshimura, F.
Yakushiji, S. Kondo, X. Wu, M. Shindo, K. Shishido, Org. Lett. 2006, 8, 475;
(d) A. K. Ghosh, G. Gong, Org. Lett. 2007, 9, 1437; (e) B. M. Trost, C. E.
Stivala, K. L. Hull, A. Huang, D. R. Fandrick, J. Am. Chem. Soc. 2014, 136,
Scheme 5. Completion of lasonolide A. py = pyridine.
In summary, a modular strategy for the concise synthesis of
lasonolide A was achieved. The salient feature is the development
of an enantioconvergent approach for accessing the two chiral
tetrahydropyran motifs bearing multiple stereocenters from one
This article is protected by copyright. All rights reserved.